BFTC909 NTCC?人腎盂移行細(xì)胞癌細(xì)胞株human renal pelvis transitional cell carcinoma cell line

BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心

The BFTC909 cell line is a human renal pelvis transitional cell carcinoma cell line. It has been widely used in cancer research, particularly in studies related to bladder cancer.

BFTC909 cell line

Key Characteristics:

• Origin: Derived from a human renal pelvis transitional cell carcinoma of a 64-year-old man in a blackfoot disease endemic area in Taiwan.

• Morphology: Epithelial-like cells

• Tumorigenicity: Can form tumors in nude mice

• Genetic Alterations: Known to harbor genetic alterations, including mutations in the TP53 and RAS genes.

Applications in Research:

The BFTC909 cell line has been used in various research areas, including:

• Bladder cancer research: Studying the molecular mechanisms of bladder cancer development and progression, particularly in the context of environmental factors associated with blackfoot disease.

• Drug development and screening: Evaluating the efficacy and toxicity of potential anticancer drugs.

• Cell biology: Investigating cellular processes such as cell cycle regulation, apoptosis, and signal transduction pathways.

Limitations:

• Immortalized cell line: May not perfectly reflect the behavior of primary tumor cells.

• Potential for genetic drift: Prolonged culture can lead to changes in the cell line's genetic makeup.

生產(chǎn)廠家Supplier:

BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心

E-mail:[email protected]

http://www.nedfriskphoto.com